Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 24;61(1):367-376.
doi: 10.1093/rheumatology/keab362.

All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study

Bahar Moghaddam  1 , Shelby Marozoff  2 , Lingyi Li  2   3 , Eric C Sayre  2 , J Antonio Aviña- Zubieta  2   3   4
Affiliations

All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study

Bahar Moghaddam et al. Rheumatology (Oxford). .

Abstract

Objective: To investigate all-cause and cause-specific mortality in SLE patients between two time periods, 1997-2005 and 2006-14.

Methods: We used an administrative health database from the province of British Columbia, Canada to match all incident SLE patients to 10 non-SLE individuals on sex, age and index date. Cohorts were divided into two subgroups, according to diagnosis year: early cohort 1997-2005 and late cohort 2006-14. The outcome was death [all-cause, renal disease, cancer, infection, cardiovascular disease (CVD) and other]. Hazard ratios (HR) and 95% CIs were estimated using univariate and multivariable Cox models.

Results: Among 6092 SLE patients and 60 920 non-SLE individuals, there were 451 and 1910 deaths, respectively. The fully adjusted all-cause mortality HR (95% CI) in the overall SLE cohort was 1.85 (1.66, 2.06), with no statistically significant improvement between early and late cohorts [1.95 (1.69, 2.26) vs 1.74 (1.49, 2.04)]. There was excess mortality from renal disease [3.04 (2.29, 4.05)], infections [2.74 (2.19, 3.43)] and CVD [2.05 (1.77, 2.38)], but not cancer [1.18 (0.96, 1.46)], in the overall SLE cohort. There was no statistically significant improvement in cause-specific mortality between early and late cohorts for renal disease [3.57 (2.37, 5.36) vs 2.65 (1.78, 3.93)], infection [2.94 (2.17, 3.98) vs 2.54 (1.84, 3.51)] and CVD [1.95 (1.60, 2.38) vs 2.18 (1.76, 2.71)]. There was no increase in cancer-related mortality in either cohort [1.27 (0.96, 1.69) vs 1.10 (0.82, 1.48)].

Conclusion: This population-based study demonstrates a persisting mortality gap in all-cause and cause-specific deaths in SLE patients, compared with the general population.

Keywords: Key words: systemic lupus erythematosus; cancer; cohort; epidemiology; mortality; risk.

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
Death in SLE and non-SLE cohorts Cumulative incidence of (A) all-cause, (B) renal disease, (C) cardiovascular disease, (D) cancer, (E) infection and (F) other causes of death in SLE and non-SLE cohorts.
See this image and copyright information in PMC

References

    1. Rahman A, Isenberg DA.. Systemic lupus erythematosus. N Engl J Med 2008;358:929–39. - PubMed
    1. Lisnevskaia L, Murphy G, Isenberg D.. Systemic lupus erythematosus. Lancet 2014;384:1878–88. - PubMed
    1. Yurkovich M, Vostretsova K, Chen W, Aviña‐Zubieta JA.. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014;66:608–16. - PubMed
    1. Lee YH, Choi SJ, Ji JD, Song GG.. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 2016;25:727–34. - PubMed
    1. Bernatsky S, Boivin J-F, Joseph L. et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7. - PubMed

Publication types

Grants and funding